166 related articles for article (PubMed ID: 24079327)
1. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
Wang J; Jia J; Liu J; He H; Zhang W; Li Z
Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins.
Jia J; Xiao Y; Liu J; Zhang W; He H; Chen L; Zhang M
J Pharm Sci; 2012 Aug; 101(8):2900-8. PubMed ID: 22628199
[TBL] [Abstract][Full Text] [Related]
3. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.
He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J
Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.
Zhang W; He H; Liu J; Wang J; Zhang S; Zhang S; Wu Z
Biomaterials; 2013 Jan; 34(1):306-19. PubMed ID: 23069716
[TBL] [Abstract][Full Text] [Related]
6. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy.
Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z
ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.
He H; Zhang M; Liu L; Zhang S; Liu J; Zhang W
Pharm Res; 2015 Oct; 32(10):3415-31. PubMed ID: 26040661
[TBL] [Abstract][Full Text] [Related]
8. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
Zhang WL; Xiao Y; Liu JP; Wu ZM; Gu X; Xu YM; Lu H
Int J Pharm; 2011 Oct; 419(1-2):314-21. PubMed ID: 21835236
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
[TBL] [Abstract][Full Text] [Related]
10. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.
Mooberry LK; Nair M; Paranjape S; McConathy WJ; Lacko AG
J Drug Target; 2010 Jan; 18(1):53-8. PubMed ID: 19637935
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.
McConathy WJ; Nair MP; Paranjape S; Mooberry L; Lacko AG
Anticancer Drugs; 2008 Feb; 19(2):183-8. PubMed ID: 18176115
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
[TBL] [Abstract][Full Text] [Related]
13. Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells.
Li J; Han M; Li J; Ge Z; Wang Q; Zhou K; Yin X
Drug Deliv; 2020 Dec; 27(1):530-541. PubMed ID: 32241173
[TBL] [Abstract][Full Text] [Related]
14. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.
Liang HQ; Rye KA; Barter PJ
J Lipid Res; 1996 Sep; 37(9):1962-70. PubMed ID: 8895062
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
[TBL] [Abstract][Full Text] [Related]
17. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins.
Rye KA; Hime NJ; Barter PJ
J Biol Chem; 1996 Feb; 271(8):4243-50. PubMed ID: 8626769
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of phosphatidylcholine by hepatic lipase in discoidal and spheroidal recombinant high-density lipoprotein.
Tansey JT; Thuren TY; Jerome WG; Hantgan RR; Grant K; Waite M
Biochemistry; 1997 Oct; 36(40):12227-34. PubMed ID: 9315860
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
